Literature DB >> 16360400

Persistently elevated parathyroid hormone levels after parathyroid surgery.

Tracy S Wang1, Samuel T Ostrower, Keith S Heller.   

Abstract

BACKGROUND: Persistent elevation of serum parathyroid hormone (PTH), despite normocalcemia, occurs in 8% to 40% of patients after parathyroidectomy. Explanations have included hypocalcemia owing to vitamin D deficiency or bone remineralization, and persistent hyperparathyroidism.
METHODS: A retrospective chart review of 816 consecutive patients who underwent surgery for primary hyperparathyroidism was conducted.
RESULTS: One hundred fourteen patients (15%) had persistently elevated PTH levels (PPTH). Patients with PPTH had higher preoperative PTH levels than those with normal PTH levels postoperatively. They also had lower postoperative Ca(++) and vitamin D levels. Multiple gland enlargement was identified in fewer patients with PPTH than in those with normal postoperative PTH levels. In patients with PPTH and a postoperative Ca(++) less than 9.6 mg/dL (group I), there was a greater decrease in IOPTH, a higher initial postoperative PTH level, and a lower postoperative vitamin D level than in PPTH patients whose postoperative Ca(++) was > or =9.6 mg/dL (group II). Postoperative Ca(++) and vitamin D levels were also lower in patients whose PPTH did not ultimately resolve. Three patients in group II had recurrent disease.
CONCLUSIONS: Persistent elevation of postoperative serum PTH levels in normocalcemic patients is associated with mild hypocalcemia, probably owing to vitamin D deficiency. In some patients it may also be indicative of mild persistent hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16360400     DOI: 10.1016/j.surg.2005.08.026

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  15 in total

1.  Elevated parathyroid hormone after parathyroidectomy delays symptom improvement.

Authors:  Priya R Pathak; Sara E Holden; Sarah C Schaefer; Glen Leverson; Herbert Chen; Rebecca S Sippel
Journal:  J Surg Res       Date:  2014-03-02       Impact factor: 2.192

Review 2.  Persistent and recurrent hyperparathyroidism.

Authors:  Carole Guerin; Nunzia Cinzia Paladino; Aoife Lowery; Fréderic Castinetti; David Taieb; Fréderic Sebag
Journal:  Updates Surg       Date:  2017-04-22

3.  The impact of vitamin D status and tumor size on the intraoperative parathyroid hormone dynamics in patients with symptomatic primary hyperparathyroidism.

Authors:  Gaurav Agarwal; Dhalapathy Sadacharan; Pooja Ramakant; Manoj Shukla; Saroj K Mishra
Journal:  Surg Today       Date:  2012-01-05       Impact factor: 2.549

Review 4.  Elevated parathyroid hormone levels after successful parathyroidectomy for primary hyperparathyroidism: a clinical review.

Authors:  Roberto de la Plaza Llamas; José Manuel Ramia Ángel; Vladimir Arteaga Peralta; Cristina García Amador; Aylhín Joana López Marcano; Aníbal Armando Medina Velasco; Begoña González Sierra; Alba Manuel Vázquez; Raquel Aránzazu Latorre Fragua
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-05       Impact factor: 2.503

5.  Predictors of recurrence in primary hyperparathyroidism: an analysis of 1386 cases.

Authors:  David F Schneider; Haggi Mazeh; Herbert Chen; Rebecca S Sippel
Journal:  Ann Surg       Date:  2014-03       Impact factor: 12.969

6.  Significance of rebounding parathyroid hormone levels during parathyroidectomy.

Authors:  David F Schneider; Kristin A Ojomo; Haggi Mazeh; Sarah C Oltmann; Rebecca S Sippel; Herbert Chen
Journal:  J Surg Res       Date:  2013-05-03       Impact factor: 2.192

7.  Justified follow-up: a final intraoperative parathyroid hormone (ioPTH) Over 40 pg/mL is associated with an increased risk of persistence and recurrence in primary hyperparathyroidism.

Authors:  Mohammad H Rajaei; Alex M Bentz; David F Schneider; Rebecca S Sippel; Herbert Chen; Sarah C Oltmann
Journal:  Ann Surg Oncol       Date:  2014-09-06       Impact factor: 5.344

8.  [Primary hyperparathyroidism. Postoperative normocalcemic hyperparathyrinemia after curative parathyroidectomy].

Authors:  M Hermann
Journal:  Chirurg       Date:  2010-05       Impact factor: 0.955

Review 9.  Peer-reviewed, evidence-based analysis of vitamin D and primary hyperparathyroidism.

Authors:  Storm Weaver; David B Doherty; Camilo Jimenez; Nancy D Perrier
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

10.  Intraoperative PTH Assay during Minimally Invasive Parathyroidectomy May Be Helpful in the Detection of Double Adenomas and May Minimise the Risk of Recurrent Surgery.

Authors:  E Ypsilantis; H Charfare; W S Wassif
Journal:  Int J Endocrinol       Date:  2010-12-15       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.